Handelsbanken Fonder’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $113M | Buy |
1,089,694
+496,124
| +84% | +$44.3M | 0.32% | 53 |
|
|
2026
Q1 | $42.6M | Sell |
593,570
-701
| -0.1% | -$54K | 0.14% | 125 |
|
|
2025
Q4 | $47.2M | Buy |
594,271
+2,860
| +0.5% | +$225K | 0.14% | 126 |
|
|
2025
Q3 | $44.6M | Sell |
591,411
-1,456
| -0.2% | -$99.8K | 0.14% | 139 |
|
|
2025
Q2 | $40.9M | Buy |
592,867
+8,653
| +1% | +$567K | 0.15% | 134 |
|
|
2025
Q1 | $39.6M | Sell |
584,214
-19,011
| -3% | -$1.14M | 0.16% | 126 |
|
|
2024
Q4 | $27.1M | Buy |
603,225
+20,955
| +4% | +$1.18M | 0.1% | 179 |
|
|
2024
Q3 | $36.6M | Buy |
582,270
+7,681
| +1% | +$448K | 0.14% | 146 |
|
|
2024
Q2 | $33.9M | Sell |
574,589
-7,608
| -1% | -$476K | 0.15% | 139 |
|
|
2024
Q1 | $46.4M | Buy |
582,197
+24,441
| +4% | +$1.87M | 0.2% | 110 |
|
|
2023
Q4 | $44M | Buy |
557,756
+69,594
| +14% | +$4.95M | 0.21% | 105 |
|
|
2023
Q3 | $34.1M | Sell |
488,162
-97,838
| -17% | -$6.93M | 0.19% | 120 |
|
|
2023
Q2 | $40.5M | Buy |
586,000
+54,564
| +10% | +$3.88M | 0.22% | 107 |
|
|
2023
Q1 | $39.5M | Buy |
531,436
+98,148
| +23% | +$8.23M | 0.23% | 105 |
|
|
2022
Q4 | $40.4M | Buy |
433,288
+64,063
| +17% | +$6.18M | 0.25% | 95 |
|
|
2022
Q3 | $35.2M | Buy |
369,225
+24,260
| +7% | +$2.4M | 0.24% | 103 |
|
|
2022
Q2 | $32M | Buy |
344,965
+32,440
| +10% | +$3.17M | 0.21% | 115 |
|
|
2022
Q1 | $31.6M | Sell |
312,525
-2,193
| -0.7% | -$230K | 0.18% | 130 |
|
|
2021
Q4 | $32.5M | Sell |
314,718
-19,206
| -6% | -$1.77M | 0.16% | 143 |
|
|
2021
Q3 | $28.3M | Buy |
333,924
+8,888
| +3% | +$744K | 0.15% | 154 |
|
|
2021
Q2 | $27.1M | Buy |
325,036
+4,281
| +1% | +$351K | 0.14% | 159 |
|
|
2021
Q1 | $24.1M | Buy |
320,755
+10,326
| +3% | +$752K | 0.14% | 157 |
|
|
2020
Q4 | $21.2M | Buy |
310,429
+3,266
| +1% | +$212K | 0.13% | 162 |
|
|
2020
Q3 | $17.9M | Buy |
307,163
+6,573
| +2% | +$409K | 0.13% | 162 |
|
|
2020
Q2 | $19.5M | Buy |
+300,590
| New | +$18.9M | 0.16% | 132 |
|
|
2016
Q4 | – | Sell |
-180,500
| Closed | -$16.1M | – | 162 |
|
|
2016
Q3 | $16.1M | Sell |
180,500
-4,400
| -2% | -$415K | 0.47% | 75 |
|
|
2016
Q2 | $17.7M | Hold |
184,900
| – | – | 0.73% | 56 |
|
|
2016
Q1 | $19.2M | Sell |
184,900
-140,991
| -43% | -$13.7M | 0.82% | 45 |
|
|
2015
Q4 | $31.9M | Buy |
+325,891
| New | +$31.9M | 0.62% | 42 |
|
Other funds holding CVS
Handelsbanken Fonder's CVS Position: Q2 2026 in Review
Handelsbanken Fonder increased its CVS Health (CVS) stake by 84% in Q2 2026, buying an estimated $44.3M and bringing the position to 1,089,694 shares worth $113M. The position accounts for 0.32% of the portfolio, ranked #53.
Handelsbanken Fonder first reported a position in CVS in Q4 2015 and has held it in 29 quarters since. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Handelsbanken Fonder held 1,089,694 shares of CVS Health worth $113M as of Q2 2026.
- Handelsbanken Fonder bought 496,124 CVS Health shares in Q2 2026, an estimated $44.3M.
- CVS Health made up 0.32% of Handelsbanken Fonder's portfolio in Q2 2026, its #53 holding.
- Handelsbanken Fonder first reported a position in CVS Health in Q4 2015 and has held it in 29 quarters since.
- 2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.